Literature DB >> 19002927

SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture.

Ernst-Jürgen Schlaeger1, Eric A Kitas, Arnulf Dorn.   

Abstract

A transient transfection process was established using a novel 'in-house' developed transfection reagent, Ro-1539. It allows rapid production of large quantities of various recombinant proteins. Here we describe the transient expression of the secreted human placental alkaline phosphatase (SEAP) by HEK293EBNA and CHO cells in serum-free suspension culture. Unexpectedly, high expression levels of SEAP (150 mug/ml) were found 3-4 days post-transfection when placental alkaline phosphatase (AP) was used as the reference enzyme. To confirm these data, an SDS-PAGE analysis was performed and the visible SEAP protein band (MW of 65 kDa) was compared with co-migrated purified placental AP protein as reference. The scanning analysis of the gel showed that SEAP, a truncated form of AP, has a higher specific activity than the purified placental AP. A correction factor was introduced permitting a direct comparison of placental AP activity with the expression levels of SEAP. Scale-up of the transfection system from spinner flask to bioreactor was simple and straightforward, resulting in similar yields of SEAP. Finally, the effectiveness of Ro-1539 was compared to that of other transfection reagents.

Entities:  

Year:  2003        PMID: 19002927      PMCID: PMC3449504          DOI: 10.1023/A:1026125016602

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

1.  Use of secreted alkaline phosphatase as a reporter of gene expression in mammalian cells.

Authors:  S R Kain
Journal:  Methods Mol Biol       Date:  1997

2.  Transgenic mice as a source of fully human antibodies for the treatment of cancer.

Authors:  C G Davis; M L Gallo; J R Corvalan
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

3.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.

Authors:  J Berger; J Hauber; R Hauber; R Geiger; B R Cullen
Journal:  Gene       Date:  1988-06-15       Impact factor: 3.688

Review 4.  Chemiluminescent and bioluminescent reporter gene assays.

Authors:  I Bronstein; J Fortin; P E Stanley; G S Stewart; L J Kricka
Journal:  Anal Biochem       Date:  1994-06       Impact factor: 3.365

5.  Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections.

Authors:  V Mutel; G J Ellis; G Adam; S Chaboz; A Nilly; J Messer; Z Bleuel; V Metzler; P Malherbe; E J Schlaeger; B S Roughley; R L Faull; J G Richards
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

6.  Therapeutic antibody expression technology.

Authors:  H E Chadd; S M Chamow
Journal:  Curr Opin Biotechnol       Date:  2001-04       Impact factor: 9.740

Review 7.  Nonviral gene therapy: the promise of genes as pharmaceutical products.

Authors:  F D Ledley
Journal:  Hum Gene Ther       Date:  1995-09       Impact factor: 5.695

8.  Alkaline phosphatase as a reporter enzyme.

Authors:  K Yoon; M A Thiede; G A Rodan
Journal:  Gene       Date:  1988-06-15       Impact factor: 3.688

9.  Transient gene expression in mammalian cells grown in serum-free suspension culture.

Authors:  E J Schlaeger; K Christensen
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

10.  Optimization of culture conditions for high cell density proliferation of HL-60 human promyelocytic leukemia cells.

Authors:  B Schumpp; E J Schlaeger
Journal:  J Cell Sci       Date:  1990-12       Impact factor: 5.285

View more
  8 in total

1.  Isotope labeling in mammalian cells.

Authors:  Arpana Dutta; Krishna Saxena; Harald Schwalbe; Judith Klein-Seetharaman
Journal:  Methods Mol Biol       Date:  2012

2.  Effect of addition of 'carrier' DNA during transient protein expression in suspension CHO culture.

Authors:  Ketaki Pradhan; Mugdha Gadgil
Journal:  Cytotechnology       Date:  2012-03-14       Impact factor: 2.058

3.  Development of a generic transient transfection process at 100 L scale.

Authors:  Ola Tuvesson; Christina Uhe; Aleksei Rozkov; Elke Lüllau
Journal:  Cytotechnology       Date:  2008-02-22       Impact factor: 2.058

Review 4.  Large-scale transfection of mammalian cells for the fast production of recombinant protein.

Authors:  Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

5.  Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production.

Authors:  Sabine Geisse; Mario Henke
Journal:  J Struct Funct Genomics       Date:  2005

Review 6.  Transient transfection methods for clinical adeno-associated viral vector production.

Authors:  J Fraser Wright
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

7.  Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.

Authors:  Chaoting Liu; Brian Dalby; Weixing Chen; Jennifer M Kilzer; Henry C Chiou
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

8.  Improving the baculovirus expression vector system with vankyrin-enhanced technology.

Authors:  Kendra H Steele; Barbara J Stone; Kathleen M Franklin; Angelika Fath-Goodin; Xiufeng Zhang; Haobo Jiang; Bruce A Webb; Christoph Geisler
Journal:  Biotechnol Prog       Date:  2017-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.